October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use criteria (AUC) and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types.

Check-Cap Ltd. announced additional clinical data was recently presented on its ingestible capsule for preparation-free, minimally-invasive colorectal cancer screening. The research was presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting, Oct. 14-19 in Las Vegas, and at the United European Gastroenterology Week (UEGW), Oct. 15-19 in Vienna.

Imagine getting a medical X-ray that comes out blank – as if your bones had vanished. That’s what happened when scientists cranked up the intensity of the world’s first X-ray laser, at the Department of Energy’s SLAC National Accelerator Laboratory, to get a better look at a sample they were studying: The X-rays seemed to go right through it as if it were not there.

Based on its recent analysis of the computerized tomography (CT) market for extremity imaging, Frost & Sullivan recognizes Carestream Health with the 2016 North American Frost & Sullivan Award for New Product Innovation. Carestream's U.S. Food and Drug Administration (FDA)-approved cone beam computerized tomography (CBCT) device, the OnSight 3-D Extremity System, is proving to be a game-changer with its ergonomic design and unparalleled features, according to Frost & Sullivan. Compared to multi-detector computerized tomography (MDCT) systems, this device delivers lower dosage and provides the ability to capture weight-bearing images.